The FNIH Celebration of Science: 14th Annual Awards Ceremony celebrates scientific excellence and partnership. The program will highlight the importance of innovation and collaboration to foster breakthrough biomedical discoveries. At the center of this signature event, the FNIH recognizes the exceptional achievements of the 2026 recipients of the following honors:

• Montrone-Seigel Prize in Biomedical Sciences, recognizing outstanding achievements by promising young scientists in biomedical research.
• The Paul-Gallin Trailblazer Prize for Physician-Scientists, honoring outstanding contributions of early-career physician-scientists whose work has the potential to or has led to innovations in patient care.
• Kovler Prize for Trust in Life Science Journalism honors an individual who has significantly increased the public’s awareness and understanding of life science through their distinguished body of work through any media.
• The Charles A. Sanders, MD, Partnership Award, recognizing persons and/or organizations that have made significant contributions to the FNIH’s work to build, implement and nurture private-public partnerships in support of the mission of the National Institutes of Health (NIH).

Please join us for this exciting event, as we celebrate both excellence in science and the researchers and visionaries who are changing the face of biomedical research.

For sponsorship opportunities and ticket purchases, click here.

TIME 
Welcome Reception: 6 p.m.   
Dinner: 7 p.m.
Post Reception: 9 p.m.
All times Eastern.

THANK YOU TO OUR PREMIER SPONSORS

THANK YOU TO OUR VISIONARY SPONSORS

EVENT COUNTDOWN

ABOUT THE FNIH

The Foundation for the National Institutes of Health (FNIH) builds public-private partnerships that connect leading biomedical scientists at the National Institutes of Health (NIH) with their counterparts in life sciences companies, academia, patient organizations, foundations, and regulatory agencies (including the Food and Drug Administration and European Medicines Agency). Through team science, the FNIH solves complex health challenges and accelerates breakthroughs for patients, regardless of who they are or what health threats they face. The FNIH contributes to the development of new therapies, diagnostics, and potential cures; advances global health; and helps train the next generations of scientists. Established by Congress to support the mission of the NIH, the FNIH is a not-for-profit 501(c)(3) charitable organization. For more information about the FNIH, please visit fnih.org.